Detailed Information on Publication Record
2022
Primary Lymphomas of the Breast: A Review
JAMES, Emily R, Roberto N MIRANDA and Suzanne Dawn TURNERBasic information
Original name
Primary Lymphomas of the Breast: A Review
Authors
JAMES, Emily R, Roberto N MIRANDA and Suzanne Dawn TURNER (826 United Kingdom of Great Britain and Northern Ireland, guarantor, belonging to the institution)
Edition
JPRAS OPEN, 2022, 2352-5878
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.400
RIV identification code
RIV/00216224:14740/22:00128813
Organization unit
Central European Institute of Technology
UT WoS
000905546000018
Keywords in English
breast lymphoma; breast implant lymphoma; BIA-ALCL; non-Hodgkin lymphoma; breast implants
Tags
Tags
International impact, Reviewed
Změněno: 6/3/2023 17:54, Mgr. Pavla Foltynová, Ph.D.
Abstract
V originále
Lymphomas of the breast are rare neoplasms that arise from breast lymphoid tissue and are characterised by neoplastic B or T cells. Breast lymphomas arising from B cells include, but are not limited to, diffuse large B cell lymphoma, follicular lymphoma, extra-nodal marginal zone lymphoma and Burkitt lymphoma. Anaplastic large cell lymphoma (ALCL) is of a T cell origin and both anaplastic lymphoma kinase (ALK)-positive and ALK-negative presentations have been noted in the breast. In addition, there is a more recently identified presentation of ALK-negative ALCL that arises around textured breast implants and is usually confined to a periprosthetic fibrous capsule. Here, we discuss the clinical presentations, histological and immunohistochemical features and treatment options for each type of primary breast lymphoma. We hope that this review will highlight the importance of the timely and accurate diagnosis of breast lymphoma in order to tailor the most appropriate treatment. We also wish to raise awareness of the breast implantassociated lymphomas, with the goal of stimulating work that will aid our understanding of their epidemiology and pathogenesis.